These observations were consistent with our analysis that the DFS and OS of pMMR CRC patients with a higher infiltration level of cytotoxic CD4 + T cells are longer, which could be proposed as a prognostic biomarker in pMMR CRC and utilize in adoptive cellular therapy (63–66). This evidence concerns the gene CD4 and colorectal carcinoma.